DNA methylation in germ cell tumour aetiology: Current understanding and outstanding questions

Reproduction

Volumn 146, Issue 2, 2013, Pages

  Cusack, Martin ^a   Scotting, Paul ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACK; BREAST CANCER; CANCER INCIDENCE; CHORIOCARCINOMA; CHROMOSOME 12P; CLINICAL FEATURE; COLON CANCER; COLORECTAL CANCER; CPG ISLAND; DNA DAMAGE; DNA METHYLATION; EMBRYONAL CARCINOMA; GENE EXPRESSION; GERM CELL TUMOR; GLIOMA; HUMAN; MUTAGENESIS; NEOPLASM; NEUROBLASTOMA; PARATHYROID TUMOR; PHENOTYPE; PRIMORDIAL GERM CELL; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; TERATOMA; YOLK SAC TUMOR;

ANIMALS; BIOMEDICAL RESEARCH; DNA METHYLATION; EPIGENESIS, GENETIC; EVIDENCE-BASED MEDICINE; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS, GERM CELL AND EMBRYONAL;

EID: 84880544402     PISSN: 14701626     EISSN: 17417899     Source Type: Journal    
DOI: 10.1530/REP-12-0382     Document Type: Review

References (83)

1. Abe M, Ohira M, Kaneda A, Yagi Y, Yamamoto S, Kitano Y, Takato T, Nakagawara A & Ushijima T 2005 CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas. Cancer Research 65 828-834. (Pubitemid 40216441)
2. Alaminos M, Davalos V, Cheung NKV, Gerald WL & Esteller M 2004 Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma. Journal of the National Cancer Institute 96 1208-1219. (doi:10.1093/jnci/djh224) (Pubitemid 39232712)
3. Ang PW, Loh M, Liem N, Lim PL, Grieu F, Vaithilingam A, Platell C, Yong WP, Iacopetta B & Soong R 2010 Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features. BMC Cancer 10 227. (doi:10.1186/1471-2407-10-227)
4. Arnaud P 2010 Genomic imprinting in germ cells: imprints are under control. Reproduction 140 411-423. (doi:10.1530/REP-10-0173)
5. Bediaga NG, Acha-Sagredo A, Guerra I, Viguri A, Albaina C, Diaz IR, Rezola R, Alberdi MJ, Dopazo J, Montaner D et al. 2010 DNA methylation epigenotypes in breast cancer molecular subtypes. Breast Cancer Research 12 R77. (doi:10.1186/bcr2721)
6. van den Belt-Dusebout AW, de Wit R, Gietema JA, Horenblas S, Louwman MWJ, Ribot JG, Hoekstra HJ, Ouwens GM, Aleman BMP & van Leeuwen FE 2007 Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. Journal of Clinical Oncology 25 4370-4378. (doi:10.1200/JCO.2006. 10.5296) (Pubitemid 350013842)
7. Beyrouthy MJ, Garner KM, Hever MP, Freemantle SJ, Eastman A, Dmitrovsky E & Spinella MJ 2009 High DNA methyltransferase 3B expression mediates 5-aza-deoxycytidine hypersensitivity in testicular germ cell tumors. Cancer Research 69 9360-9366. (doi:10.1158/0008-5472.CAN-09-1490)
8. Bibikova M, Barnes B, Tsan C, Ho V, Klotzle B, Le JM, Delano D, Zhang L, Schroth GP, Gunderson KL et al. 2011 High density DNA methylation array with single CpG site resolution. Genomics 98 288-295. (doi:10.1016/j.ygeno.2011.07. 007)
9. Brait M, Maldonado L, Begum S, Loyo M, Wehle D, Tavora FF, Looijenga LHJ, Kowalski J, Zhang Z, Rosenbaum E et al. 2012 DNA methylation profiles delineate epigenetic heterogeneity in seminoma and non-seminoma. British Journal of Cancer 106 414-423. (doi:10.1038/bjc.2011.468)
10. Bussey KJ, Lawce HJ, Himoe E, Shu XO, Heerema NA, Perlman EJ, Olson SB & Magenis RE 2001 SNRPN methylation patterns in germ cell tumors as a reflection of primordial germ cell development. Genes, Chromosomes & Cancer 32 342-352. (doi:10.1002/gcc.1199) (Pubitemid 33055119)
11. Cheung HH, Lee TL, Rennert OM & Chan WJ 2009 DNA methylation of cancer genome. Birth Defects Research. Part C, Embryo Today: Reviews 87 335-350. (doi:10.1002/bdrc.20163)
12. Dawson MA & Kouzarides T 2012 Cancer epigenetics: from mechanism to therapy. Cell 150 12-27. (doi:10.1016/j.cell.2012.06.013)
13. Esteller M 2007 Cancer epigenomics: DNA methylomes and histonemodification maps. Nature Reviews. Genetics 8 286-298. (doi:10.1038/nrg2005) (Pubitemid 46439286)
14. Esteller M 2011 Cancer epigenetics for the 21st century: what's next? Genes & Cancer 2 604-606. (doi:10.1177/1947601911423096)
15. Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB & Herman JG 2000 Inactivation of the DNArepair gene MGMT and the clinical response of gliomas to alkylating agents. New England Journal of Medicine 343 1350-1354. (doi:10.1056/NEJM200011093431901)
16. Foulks JM, Parnell KM, Nix RN, Chau S, Swierczek K, Saunders M, Wright K, Hendrickson TF, Ho KK, McCullar MV et al. 2012 Epigenetic drug discovery: targeting DNA methyltransferases. Journal of Biomolecular Screening 17 2-17. (doi:10.1177/1087057111421212)
17. Frazier AL, Weldon C & Amatruda J 2012 Fetal and neonatal germ cell tumors. Seminars in Fetal & Neonatal Medicine 17 222-230. (doi:10.1016/j.siny.2012.05.004)
18. Frigola J, Song J, Stirzaker C, Hinshelwood RA, Peinado MA & Clark SJ 2006 Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. Nature Genetics 38 540-549. (doi:10.1038/ng1781)
19. Furukawa S, Haruta M, Arai Y, Honda S, Ohshima J, Sugawara W, Kageyama Y, Higashi Y, Nishida K, Tsunematsu Y et al. 2009 Yolk sac tumor but not seminoma or teratoma is associated with abnormal epigenetic reprogramming pathway and shows frequent hypermethylation of various tumor suppressor genes. Cancer Science 100 698-708. (doi:10.1111/j.1349-7006.2009.01102.x)
20. Gondos B 1993 Ultrastructure of developing and malignant germ-cells. European Urology 23 68-74.
21. Hackett JA, Reddington JP, Nestor CE, Dunican DS, Branco MR, Reichmann J, Reik W, Surani MA, Adams IR & Meehan RR 2012 Promoter DNA methylation couples genome-defence mechanisms to epigenetic reprogramming in the mouse germline. Development 139 3623-3632. (doi:10.1242/dev.081661)
22. Hajkova P 2011 Epigenetic reprogramming in the germline: towards the ground state of the epigenome. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 366 2266-2273. (doi:10.1098/rstb.2011. 0042)
23. Hansen KD, Timp W, Bravo HC, Sabunciyan S, Langmead B, McDonald OG, Wen B, Wu H, Liu Y, Diep D et al. 2011 Increased methylation variation in epigenetic domains across cancer types. Nature Genetics 43 768-775. (doi:10.1038/ng.865)
24. Hinoue T, Weisenberger DJ, Lange CPE, Shen H, Byun HM, Van Den Berg D, Malik S, Pan F, Noushmehr H, van Dijk CM et al. 2012 Genomescale analysis of aberrant DNA methylation in colorectal cancer. Genome Research 22 271-282. (doi:10.1101/gr.117523.110)
25. Holm K, Hegardt C, Staaf J, Vallon-Christersson J, Jonsson G, Olsson H, Borg A & Ringner M 2010 Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns. Breast Cancer Research 12 R36. (doi:10.1186/bcr2590)
26. Honorio S, Agathanggelou A, Wernert N, Rothe M, Maher ER & Latif F 2003 Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours. Oncogene 22 461-466. (doi:10.1038/sj.onc.1206119) (Pubitemid 36194343)
27. Horton Z, Schlatter M & Schultz S 2007 Pediatric germ cell tumors. Surgical Oncology 16 205-213. (doi:10.1016/j.suronc.2007.07.005) (Pubitemid 350086946)
28. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, Cui H, Gabo K, Rongione M, Webster M et al. 2009 The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nature Genetics 41 178-186. (doi:10.1038/ng.298)
29. Issa JP 2004 Opinion - CpG island methylator phenotype in cancer. Nature Reviews. Cancer 4 988-993. (doi:10.1038/nrc1507) (Pubitemid 39626222)
30. Jeyapalan JN, Noor DAM, Lee SH, Tan CL, Appleby VA, Kilday JP, Palmer RD, Schwalbe EC, Clifford SC,Walker DA et al. 2011 Methylator phenotype of malignant germ cell tumours in children identifies strong candidates for chemotherapy resistance. British Journal of Cancer 105 575-585. (doi:10.1038/bjc.2011.218)
31. Ji H, Ehrlich LIR, Seita J, Murakami P, Doi A, Lindau P, Lee H, Aryee MJ, Irizarry RA, Kim K et al. 2010 Comprehensive methylome map of lineage commitment from haematopoietic progenitors. Nature 467 338-342. (doi:10.1038/nature09367)
32. Johnson WE, Li C & Rabinovic A 2007 Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8 118-127. (doi:10.1093/biostatistics/kxj037) (Pubitemid 44906106)
33. Jones TD, Wang M, Sung MT, Zhang S, Ulbright TM, Eble JM, Beck SD, Foster RS, Anagnostou JJ Jr, Conner C et al. 2006 Clonal origins of metastatic testicular teratomas. Clinical Cancer Research 12 5377-5383. (doi:10.1158/1078-0432.CCR-06-0444) (Pubitemid 44497251)
34. Karpinski P, Myszka A, Ramsey D, Misiak B, Gil J, Laczmanska I, Grzebieniak Z, Sebzda T, Smigiel R, Stembalska A et al. 2010 Polymorphisms in methyl-group metabolism genes and risk of sporadic colorectal cancer with relation to the CpG island methylator phenotype. Cancer Epidemiology 34 338-344. (doi:10.1016/j.canep.2010.03.002)
35. Kato N, Tamura G, Fukase M, Shibuya H & Motoyama T 2003 Hypermethylation of the RUNX3 gene promoter in testicular yolk sac tumor of infants. American Journal of Pathology 163 387-391. (doi:10.1016/S0002-9440(10) 63668-1) (Pubitemid 36909402)
36. Kawakami T, Zhang C, Okada Y & Okamoto K 2006 Erasure of methylation imprint at the promoter and CTCF-binding site upstream of H19 in human testicular germ cell tumors of adolescents indicate their fetal germ cell origin. Oncogene 25 3225-3236. (doi:10.1038/sj.onc. 1209362) (Pubitemid 43846307)
37. Kempkensteffen C, Christoph F, Weikert S, Krause H, Kollermann J, Schostak M, Miller K & Schrader M 2006 Epigenetic silencing of the putative tumor suppressor gene testisin in testicular germ cell tumors. Journal of Cancer Research and Clinical Oncology 132 765-770. (doi:10.1007/s00432-006-0124-6) (Pubitemid 44521451)
38. Koul S, Houldsworth J, Mansukhani MM, Donadio A, McKiernan JM, Reuter VE, Bosl GJ, Chaganti RS & Murty VV 2002 Characteristic promoter hypermethylation signatures in male germ cell tumors. Molecular Cancer 1 8. (doi:10.1186/1476-4598-1-8) (Pubitemid 38751448)
39. Koul S, McKiernan JM, Narayan G, Houldsworth J, Bacik J, Dobrzynski DL, Assaad AM, Mansukhani M, Reuter VE, Bosl GJ et al. 2004 Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors. Molecular Cancer 3 16. (doi:10.1186/1476-4598-3-16) (Pubitemid 38751497)
40. Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, Larson DE, Kandoth C, Payton JE, Baty J,Welch J et al. 2010 DNMT3A mutations in acute myeloid leukemia. New England Journal of Medicine 363 2424-2433. (doi:10.1056/ NEJMoa1005143)
41. Lind GE, Skotheim RI, Fraga MF, Abeler VM, Esteller M & Lothe RA 2006 Novel epigenetically deregulated genes in testicular cancer include homeobox genes and SCGB3A1 (HIN-1). Journal of Pathology 210 441-449. (doi:10.1002/path.2064) (Pubitemid 44830604)
42. Lind GE, Skotheim RI & Lothe RA 2007 The epigenome of testicular germ cell tumors. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica 115 1147-1160. (doi:10.1111/j.1600-0463.2007.apm-660.xml.x) (Pubitemid 350179475)
43. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, Nery JR, Lee L, Ye Z, Ngo QM et al. 2009 Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462 315-322. (doi:10.1038/nature08514)
44. Looijenga LHJ 2009 Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights. Journal of Pathology 218 146-162. (doi:10.1002/path.2522)
45. Looijenga LHJ, Gillis AJM, Stoop HJ, Hersmus R & Oosterhuis JW 2007 Chromosomes and expression in human testicular germ-cell tumors. Annals of the New York Academy of Sciences 1120 187-214. (doi:10.1196/annals.1411.000)
46. Manton KJ, Douglas ML, Netzel-Arnett S, Fitzpatrick DR, Nicol DL, Boyd AW, Clements JA & Antalis TM 2005 Hypermethylation of the 50 CpG island of the gene encoding the serine protease Testisin promotes its loss in testicular tumorigenesis. British Journal of Cancer 92 760-769. (doi:10.1038/sj.bjc. 6602373) (Pubitemid 40460615)
47. Minami K, Chano T, Kawakami T, Ushida H, Kushima R, Okabe H, Okada Y & Okamoto K 2010 DNMT3L is a novel marker and is essential for the growth of human embryonal carcinoma. Clinical Cancer Research 16 2751-2759. (doi:10.1158/1078-0432.CCR-09-3338)
48. Mostert M, Rosenberg C, Stoop H, Schuyer M, Timmer A, Oosterhuis W & Looijenga L 2000 Comparative genomic and in situ hybridization of germ cell tumors of the infantile testis. Laboratory Investigation 80 1055-1064. (doi:10.1038/labinvest.3780110) (Pubitemid 30483223)
49. Murray MJ & Nicholson JC 2010 Germ cell tumours in children and adolescents. Paediatrics & Child Health 20 109-116. (doi:10.1016/j.paed. 2009.10.006)
50. Netto GJ, Nakai Y, Nakayama M, Jadallah S, Toubaji A, Nonomura N, Albadine R, Hicks JL, Epstein JI, Yegnasubramanian S et al. 2008 Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumors. Modern Pathology 21 1337-1344. (doi:10.1038/modpathol.2008.127)
51. Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, Berman BP, Pan F, Pelloski CE, Sulman EP, Bhat KP et al. 2010 Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17 510-522. (doi:10.1016/j.ccr. 2010.03.017)
52. Ogoshi K, Hashimoto SI, Nakatani Y, Qu W, Oshima K, Tokunaga K, Sugano S, Hattori M, Morishita S & Matsushima K 2011 Genome-wide profiling of DNA methylation in human cancer cells. Genomics 98 280-287. (doi:10.1016/j.ygeno. 2011.07.003)
53. Okamoto K 2012 Epigenetics: a way to understand the origin and biology of testicular germ cell tumors. International Journal of Urology 19 504-511. (doi:10.1111/j.1442-2042.2012.02986.x)
54. Ooi SKT, Qiu C, Bernstein E, Li K, Jia D, Yang Z, Erdjument-Bromage H, Tempst P, Lin SP, Allis CD et al. 2007 DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 448 714-717. (doi:10.1038/nature05987) (Pubitemid 47236857)
55. Oosterhuis JW & Looijenga LHJ 2005 Testicular germ-cell tumours in a broader perspective. Nature Reviews. Cancer 5 210-222. (doi:10.1038/nrc1568) (Pubitemid 40314952)
56. Palmer RD, Foster NA, Vowler SL, Roberts I, Thornton CM, Hale JP, Schneider DT, Nicholson JC & Coleman N 2007 Malignant germ cell tumours of childhood: new associations of genomic imbalance. British Journal of Cancer 96 667-676. (doi:10.1038/sj.bjc.6603602)
57. Palmer RD, Barbosa-Morais NL, Gooding EL, Muralidhar B, Thornton CM, Pett MR, Roberts I, Schneider DT, Thorne N, Tavare S et al. 2008 Pediatric malignant germ cell tumors show characteristic transcriptome profiles. Cancer Research 68 4239-4247. (doi:10.1158/0008-5472. CAN-07-5560)
58. Portela A & Esteller M 2010 Epigenetic modifications and human disease. Nature Biotechnology 28 1057-1068. (doi:10.1038/nbt.1685)
59. Poynter JN, Christensen B, Nelson HH, Amatruda JF, Frazier AL & Ross JA 2011 DNA methylation patterns distinguish histologic subtypes of pediatric germ cell tumours [abstract]. Cancer Research 71 (Suppl 1) Abstract nr 872.
60. Rajpert-De Meyts E & Skakkebaek NE 2011 Pathogenesis of testicular carcinoma in situ and germ cell cancer: still more questions than answers. International Journal of Andrology 34 E2-E6. (doi:10.1111/j.1365-2605.2011. 01213.x)
61. Rivenbark AG, Jones WD, Risher JD & Coleman WB 2006 DNA methylation-dependent epigenetic regulation of gene expression in MCF-7 breast cancer cells. Epigenetics 1 32-44. (doi:10.4161/epi.1.1. 2358)
62. Roll JD, Rivenbark AG, Jones WD & Coleman WB 2008 DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines. Molecular Cancer 7 15. (doi:10.1186/1476-4598-7-15) (Pubitemid 351285306)
63. Schneider DT, Schuster AE, Fritsch MK, Hu J, Olson T, Lauer S, Göbel U & Perlman EJ 2001 Multipoint imprinting analysis indicates a common precursor cell for gonadal and nongonadal pediatric germ cell tumors. Cancer Research 61 7268-7276. (Pubitemid 32946525)
64. Skakkebaek NE, Berthelsen JG, Giwercman A & Muller J 1987 Carcinoma in situ of the testis - possible origin from gonocytes and precursor of all types of germ-cell tumors except spermatocytoma. International Journal of Andrology 10 19-28. (doi:10.1111/j.1365-2605.1987.tb00161.x) (Pubitemid 17081837)
65. Smiraglia DJ, Szymanska J, Kraggerud SM, Lothe RA, Peltomaki P & Plass C 2002 Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumors. Oncogene 21 3909-3916. (doi:10.1038/sj.onc.1205488) (Pubitemid 34620859)
66. Smith-Sorensen B, Lind GE, Skotheim RI, Fossa SD, Fodstad O, Stenwig AE, Jakobsen KS & Lothe RA 2002 Frequent promoter hypermethylation of the O-6-methylguanine-DNA methyltransferase (MGMT) gene in testicular cancer. Oncogene 21 8878-8884. (doi:10.1038/sj.onc. 1205978) (Pubitemid 36132408)
67. Sohn BH, Park IY, Lee JJ, Yang SJ, Jang YJ, Park KC, Kim DJ, Lee DC, Sohn HA, Kim TWet al. 2010 Functional switching of TGF-β1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter. Gastroenterology 138 1898-1908. (doi:10.1053/j.gastro. 2009.12.044)
68. Starker LF, Svedlund J, Udelsman R, Dralle H, Åkerström G, Westin G, Lifton RP, Björklund P & Carling T 2011 The DNA methylome of benign and malignant parathyroid tumors. Genes, Chromosomes & Cancer 50 735-745. (doi:10.1002/gcc.20895)
69. Tan C & Scotting PJ 2013 Stem cell research points the way to the cell of origin for intracranial germ cell tumours. An alternative cell of origin for intracranial germ cell tumours. Journal of Pathology 229 4-11. (doi:10.1002/path.4098)
70. Tiwari VK, McGarvey KM, Licchesi JDF, Ohm JE, Herman JG, Schubeler D & Baylin SB 2008 PcG proteins, DNA methylation, and gene repression by chromatin looping. PLoS Biology 6 2911-2927. (doi:10.1371/journal. pbio.0060306)
71. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB & Issa JPJ 1999 CpG island methylator phenotype in colorectal cancer. PNAS 96 8681-8686. (doi:10.1073/pnas.96.15.8681) (Pubitemid 29354851)
72. Ulbright TM 2005 Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Modern Pathology 18 S61-S79. (doi:10.1038/modpathol. 3800310) (Pubitemid 40192565)
73. Ushida H, Kawakami T, Minami K, Chano T, Okabe H, Okada Y & Okamoto K 2012 Methylation profile of DNA repetitive elements in human testicular germ cell tumor. Molecular Carcinogenesis 51 711-722. (doi:10.1002/mc.20831)
74. Veltman IM, SchepensMT, Looijenga LHJ, Strong LC & Van Kessel AG 2003 Germ cell tumours in neonates and infants: a distinct subgroup? APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica 111 152-160. (doi:10.1034/j.1600-0463.2003.1110119-1.x) (Pubitemid 36566685)
75. van Vlodrop IJH, Niessen HEC, Derks S, Baldewijns M, van Criekinge W, Herman JG & van Engeland M 2011 Analysis of promoter CpG island hypermethylation in cancer: location, location, location! Clinical Cancer Research 17 4225-4231. (doi:10.1158/1078-0432.CCR-10-3394)
76. Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, Lam WL & Schuebeler D 2005 Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nature Genetics 37 853-862. (doi:10.1038/ng1598) (Pubitemid 41077111)
77. Weber M, Hellmann I, Stadler MB, Ramos L, Paabo S, Rebhan M & Schubeler D 2007 Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nature Genetics 39 457-466. (doi:10.1038/ng1990) (Pubitemid 46514772)
78. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, Kang GH, Widschwendter M, Weener D, Buchanan D et al. 2006 CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nature Genetics 38 787-793. (doi:10.1038/ng1834) (Pubitemid 43980599)
79. Wermann H, Stoop H, Gills AJM, Honecker F, van Gurp R, Ammerpohl O, Richter J, Oosterhuis JW, Bokemeyer C & Looijenga LHJ 2010 Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance. Journal of Pathology 221 433-442. (doi:10.1002/path.2725)
80. Wienholz BL, Kareta MS, Moarefi AH, Gordon CA, Ginno PA & Chedin F 2010 DNMT3L modulates significant and distinct flanking sequence preference for DNA methylation by DNMT3A and DNMT3B in vivo. PLoS Genetics 6 e1001106. (doi:10.1371/journal.pgen.1001106)
81. Yamashita K, Dai T, Dai Y, Yamamoto F & Perucho M 2003 Genetics supersedes epigenetics in colon cancer phenotype. Cancer Cell 4 121-131. (doi:10.1016/S1535-6108(03) 00190-9) (Pubitemid 37040828)
82. Yan XJ, Xu J, Gu ZH, Pan CM, Lu G, Shen Y, Shi JY, Zhu YM, Tang L, Zhang XWet al. 2011 Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nature Genetics 43 309-315. (doi:10.1038/ng.788)
83. Zinn RL, Pruitt K, Eguchi S, Baylin SB & Herman JG 2007 hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site. Cancer Research 67 194-201. (doi:10.1158/0008-5472.CAN-06-3396) (Pubitemid 46142775)